Li Gan Pharmaceutical Co., Ltd., founded in 1998 and headquartered in Beijing, China, is a biopharmaceutical enterprise integrating scientific research, development, production and sales. The company focuses on the field of diabetes treatment, developing and producing insulin drugs and other biological products. Li Gan Pharmaceutical has a high reputation and market share in China insulin market, and is expanding the international market.
Therefore, the name of Li Gan Pharmaceutical reflects the cooperative spirit of its founders, Dr. Gan Zhongru and Mr. Li Yikui, and their common goal of innovative drug research and development and improving human health.